Nathalie Massy

766 total citations
27 papers, 422 citations indexed

About

Nathalie Massy is a scholar working on Surgery, Infectious Diseases and Pharmacology. According to data from OpenAlex, Nathalie Massy has authored 27 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Nathalie Massy's work include Drug-Induced Adverse Reactions (6 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Nathalie Massy is often cited by papers focused on Drug-Induced Adverse Reactions (6 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (3 papers). Nathalie Massy collaborates with scholars based in France, Tunisia and Germany. Nathalie Massy's co-authors include C. Noblet, I. Marie, Christian Thuillez, Nadine Petitpain, Pierre Gillet, Pascal Demoly, Clotilde Latarche, Paul‐Michel Mertès, D Lévy-Brühl and Corinne Ruckly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Hepatology.

In The Last Decade

Nathalie Massy

21 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Massy France 11 128 94 85 73 68 27 422
Hwan Soo Kim South Korea 13 187 1.5× 72 0.8× 15 0.2× 4 0.1× 9 0.1× 64 486
A Schaeffer France 14 89 0.7× 99 1.1× 8 0.1× 16 0.2× 27 0.4× 45 575
Mirna Sučić Croatia 8 45 0.4× 112 1.2× 14 0.2× 3 0.0× 26 0.4× 26 399
Marie Simon France 10 109 0.9× 235 2.5× 31 0.4× 26 0.4× 10 0.1× 20 569
Wassan Nori Iraq 11 28 0.2× 63 0.7× 7 0.1× 25 0.3× 18 0.3× 83 319
L. Tkatch United States 8 172 1.3× 120 1.3× 4 0.0× 159 2.2× 10 0.1× 11 691
Katja Rothfuss Germany 6 92 0.7× 157 1.7× 5 0.1× 6 0.1× 9 0.1× 8 310
Deyun Cheng China 13 40 0.3× 48 0.5× 6 0.1× 5 0.1× 10 0.1× 33 437
Iqbal Ahmed India 10 104 0.8× 60 0.6× 3 0.0× 19 0.3× 6 0.1× 27 361
A. Hugo Montes Spain 12 84 0.7× 116 1.2× 8 0.1× 3 0.0× 39 0.6× 16 407

Countries citing papers authored by Nathalie Massy

Since Specialization
Citations

This map shows the geographic impact of Nathalie Massy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Massy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Massy more than expected).

Fields of papers citing papers by Nathalie Massy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Massy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Massy. The network helps show where Nathalie Massy may publish in the future.

Co-authorship network of co-authors of Nathalie Massy

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Massy. A scholar is included among the top collaborators of Nathalie Massy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Massy. Nathalie Massy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petitpain, Nadine, et al.. (2024). Atazanavir-induced lithiasis evidenced several years after drug discontinuation. AIDS. 38(10). 1604–1605.
2.
3.
Massy, Nathalie, et al.. (2023). COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance. Therapies. 78(5). 489–498. 1 indexed citations
4.
Moulis, Guillaume, Étienne Crickx, Laure Thomas, et al.. (2022). De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring. Blood. 139(16). 2561–2565. 12 indexed citations
5.
6.
Brès, Virginie, et al.. (2022). Comprehensive description of adult-onset Still's disease after COVID-19 vaccination. Journal of Autoimmunity. 134. 102980–102980. 5 indexed citations
7.
Lacroix, Clémence, Francesco Salvo, Valérie Gras‐Champel, et al.. (2021). French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge. Therapies. 76(4). 297–303. 17 indexed citations
8.
Bertrand, Valérie, Nathalie Massy, Valérie Gras, et al.. (2021). Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review. Frontiers in Pediatrics. 9. 712413–712413. 7 indexed citations
9.
Barbay, Virginie, et al.. (2021). First observation of inhibitor development against efmoroctocog alfa in France. Transfusion and Apheresis Science. 60(4). 103128–103128.
10.
Fontanilles, Maxime, Nathalie Massy, Tony Pereira, et al.. (2020). Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma. Fundamental and Clinical Pharmacology. 34(4). 484–494. 2 indexed citations
11.
Brunel, Valéry, et al.. (2019). Atazanavir urolithiasis without recent intake of atazanavir. Annales de biologie clinique. 77(4). 459–460. 2 indexed citations
12.
Massy, Nathalie, et al.. (2019). Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review. SHILAP Revista de lepidopterología. 6(Vol 6 Iss 12). 1283–1283. 4 indexed citations
13.
Armengol, G., Laurence Bouillet, Isabelle Boccon‐Gibod, et al.. (2015). Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database. Journal of Clinical Immunology. 36(1). 95–102. 20 indexed citations
14.
Ngo, Stéphanie, Y. Benhamou, G. Armengol, et al.. (2015). Agranulocytose à la fluindione : à propos d’un cas. La Revue de Médecine Interne. 37(1). 58–61.
15.
Grandvuillemin, Aurélie, Marie‐Noëlle Beyens, Nathalie Massy, et al.. (2014). Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals. Drug Safety. 37(4). 269–282. 15 indexed citations
16.
Duval-Modeste, Anne-Bénédicte, P. Joly, Nathalie Massy, et al.. (2013). First case of drug rash eosinophilia and systemic symptoms due to boceprevir. Journal of Hepatology. 60(4). 891–893. 11 indexed citations
17.
Tétart, F., et al.. (2012). Toxidermies eczématiformes au clopidogrel : à propos de quatre cas. Annales de Dermatologie et de Vénéréologie. 139(12). B292–B293. 2 indexed citations
18.
Gueudry, J., et al.. (2012). Pseudo-uvéite sévère associée à l’utilisation de moxifloxacine. Journal Français d Ophtalmologie. 36(2). 146–150. 12 indexed citations
19.
Caron, François, Isabelle Parent du Châtelet, Jean‐Philippe Leroy, et al.. (2011). From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak. The Lancet Infectious Diseases. 11(6). 455–463. 85 indexed citations
20.
Legros, Fabrice, Jean‐Philippe Leroy, Nathalie Massy, et al.. (2007). Yellow fever: epidemiology and vaccination for travelers.. 236–238.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hwan Soo Kim Breakdown of academic impact, for papers by A Schaeffer Breakdown of academic impact, for papers by Mirna Sučić Breakdown of academic impact, for papers by Marie Simon Breakdown of academic impact, for papers by Wassan Nori Breakdown of academic impact, for papers by L. Tkatch Breakdown of academic impact, for papers by Katja Rothfuss Breakdown of academic impact, for papers by Deyun Cheng Breakdown of academic impact, for papers by Iqbal Ahmed Breakdown of academic impact, for papers by A. Hugo Montes
Rankless by CCL
2026